
Women’s health company HerMD, which specializes in menopause and sexual healthcare, has announced it will close all locations effective March 21, 2025. The news comes after the company secured $18 million in additional Series A funding to fuel expansion plans in 2023.
In an email sent to patients on February 24, the HerMD leadership team cited “ongoing challenges in healthcare” that made it “increasingly difficult to sustain the quality care we provide and that we know our patients truly deserve.” The company reported having served more than 25,000 patients across multiple states during its operation.
Founded by Dr. Somi Javaid in 2015, HerMD began with a single clinic in Cincinnati before expanding to multiple locations across Ohio, Kentucky, Tennessee, Indiana, and New Jersey. The company distinguished itself by offering longer appointment times (20-60 minutes) and comprehensive women’s healthcare services focused on menopause and sexual health—areas where traditional healthcare often falls short.
The closure announcement represents a significant setback for women’s health services, particularly considering HerMD’s ambitious growth trajectory. In July 2023, when announcing its $18 million funding extension led by JAZZ Venture Partners with participation from Amboy Street Ventures and B-Flexion, the company outlined plans to expand to over 200 clinics, including locations in New York City and Nashville.
That funding round had brought HerMD’s total investment to approximately $30 million, with the capital earmarked for brick-and-mortar expansion, development of virtual services, enhancement of provider training through HerMD University, and investment in technologies for sexual health and menopause care.
HerMD’s business model addressed several barriers to quality women’s healthcare, including stigma around sexual health, rushed appointments, and limited insurance coverage for innovative treatments. Unlike many boutique practices, HerMD accepted insurance and Medicare, making specialized care more accessible.
The company also focused on provider education through its HerMD University program, addressing the statistic that less than 20% of OBGYNs are trained in menopause and sexual health care.
HerMD has notified patients that they will assist with medical records transfers and provided contact information for questions before and after the March 21 closure date. The company did not specify which particular healthcare challenges led to the shutdown.